Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography

Thrombosis Research

Volumn 113, Issue 5, 2004, Pages 341-343

  Siegling, Sabine ^a   Thyzel, Elmar ^a   Brinkmann, Thomas ^a   Prohaska, Wolfgang ^a   Glahn, Joerg ^b   Götting, Christian ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b KLINIKUM MINDEN   (Germany)

Author keywords

Mutational screening; Promoter; Sequence variations; Tissue factor pathway inhibitor 2 (TFPI 2)

Indexed keywords

PLACENTA PROTEIN 5;

DENATURATION; DNA EXTRACTION; DNA POLYMORPHISM; DNA TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIA; LETTER; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; THROMBOPHILIA;

ADULT; ALLELES; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; FEMALE; GENE FREQUENCY; GLYCOPROTEINS; HUMANS; MALE; NUCLEIC ACID DENATURATION; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 2942527218     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.03.019     Document Type: Letter

References (13)

1. Sprecher C.A., Kisiel W., Mathewes S., Foster D.C. Molecular cloning, expression, and partial characterization of a second human tissue-factor- pathway-inhibitor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3353-3357
2. Kleesiek K., Schmidt M., Götting C., Brinkmann T., Prohaska W. A first mutation in the human tissue factor pathway inhibitor gene encoding [P151L]TFPI. Blood. 92:1998;3976-3977
3. Moatti D., Seknadji P., Galand C., Poirier O., Fumeron F., Desprez S., et al. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects: impact of the V264M substitution on plasma levels of TFPI. Arterioscler. Thromb. Vasc. Biol. 19:1999;862-869
4. Miyata T., Sakata T., Kumeda K., Uchida K., Tsushima M., Fujimura H., et al. C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb. Haemost. 80:1998;345-346
5. Moatti D., Haidar B., Fumeron F., Gauci L., Boudvillain O., Seknadji P., et al. A new T-287C polymorphism in the 5′ regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphism with coronary artery disease and plasma TFPI levels. Thromb. Haemost. 84:2000;244-249
6. Amini-Nekoo A., Futers T.S., Moia M., Mannucci P.M., Grant P.J., Ariens R.A. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br. J. Haematol. 113:2001;537-543
7. Petersen L.C., Sprecher C.A., Foster D.C., Blumberg H., Hamamoto T., Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry. 35:1996;266-272
8. Blindt R., Vogt F., Lamby D., Zeiffer U., Krott N., Hilger-Eversheim K., et al. Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J. Vasc. Res. 39:2002;340-352
9. Konduri S.D., Rao C.N., Chandrasekar N., Tasiou A., Mohanam S., Kin Y., et al. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene. 20:2001;6938-6945
10. Rao C.N., Lakka S.S., Kin Y., Konduri S.D., Fuller G.N., Mohanam S., et al. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clin. Cancer Res. 7:2001;570-576
11. Kamei S., Kazama Y., Kuijper J.L., Foster D.C., Kisiel W. Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene. Biochem. Biophys. Acta. 1517:2001;430-435
12. Hube F., Reverdiau P., Iochmann S., Cherpi-Antar C., Gruel Y. Characterization and functional analysis of TFPI-2 gene promoter in human choriocarcinoma cell line. Thromb. Res. 109:2003;207-215
13. Butzow R., Alfthan H., Stenman U.H., Suikkari A.M., Bohn H., Seppala M. Immunofluometric demonstration and quantification on placental protein 5 in the absence of pregnancy. Clin. Chem. 1988;1591-1593